IP Library Granted Patent US 8,545,806
Granted Patent B2
US 8,545,806 · App. 12/384,212 · Granted Oct 1, 2013

Compositions and methods for biological remodeling with frozen particle compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,545,806
App. No.
12/384,212
Granted
Oct 1, 2013
Kind
B2
Abstract

Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one biological tissue.

Claims (24)

1. A frozen particle composition, comprising:

one or more frozen solvent particles of at least one of acetone, ethyl acetate, dimethyl formamide, dioxane, tetrahydrofuran, acetronitrile, hexamethylphosphorotriamide, tert-butyl alcohol, formic acid, hydrogen fluoride, ammonia, benzene, carbon tetrachloride, acetonitrile, hexane, dichloromethane, methylene chloride, methane, toluene, chloroform, or diethyl ether, and

including at least one biological remodeling agent of one or more of a transforming growth factor β family member, a bone morphogenetic protein, osteogenic protein, activin A, activin B, inhibin A, inhibin B, anti-mullerian hormone, or Nodal.

2. The frozen particle composition of claim 1 , further including at least one of polyethylene glycol, Ringer's solution, lactated Ringer's solution, Hartmann's solution, acetated Ringer's solution, phosphate buffered solution, TRIS-buffered saline solution, Hank's balanced salt solution, Earle's balanced salt solution, HEPES-buffered saline, dextrose, or glucose.

3. The frozen particle composition of claim 1 , wherein the at least one biological remodeling agent includes one or more extracellular matrix components.

4. The frozen particle composition of claim 1 , wherein the at least one biological remodeling agent is configured to promote growth of at least one biological tissue.

5. The frozen particle composition of claim 4 , wherein the at least one biological remodeling agent is configured to promote at least partial construction or at least partial reconstruction of at least one biological tissue.

6. The frozen particle composition of claim 4 , wherein the at least one biological remodeling agent is configured to provide at least one mechanical structure to the at least one biological tissue.

7. The frozen particle composition of claim 4 , wherein the at least one biological remodeling agent is configured to provide oxygenation, nutrition, or other nourishment to the at least one biological tissue.

8. The frozen particle composition of claim 1 , further including at least one of a nanoparticle, detection material, sensor, micro-syringe, or circuit.

9. The frozen particle composition of claim 8 , wherein the detection material includes at least one electronic identification device.

10. The frozen particle composition of claim 9 , wherein the at least one electronic identification device includes at least one radio frequency identification device.

11. The frozen particle composition of claim 8 , wherein the detection material includes at least one radioactive element.

12. The frozen particle composition of claim 8 , wherein the detection material includes at least one radioactive, luminescent, colorimetric or odorous substance.

13. The frozen particle composition of claim 8 , wherein the detection material includes at least one of a diamagnetic particle, ferromagnetic particle, paramagnetic particle, super paramagnetic contrast agent, or other magnetic particle.

14. The frozen particle composition of claim 1 , formulated to be administered to at least one substrate.

15. The frozen particle composition of claim 14 , wherein the at least one substrate includes one or more of a cell, tissue, organ, structure, or device.

16. The frozen particle composition of claim 1 , formulated to be administered by one or more of topical administration, oral administration, enteral administration, mucosal administration, percutaneous administration, or parenteral administration.

17. The frozen particle composition of claim 1 , formulated to be administered by high velocity impact.

18. The frozen particle composition of claim 1 , formulated to be administered by one or more devices.

19. The frozen particle composition of claim 1 , further including one or more of a reinforcement agent, therapeutic agent, abrasive, adhesive agent, or explosive material.

20. A frozen particle composition, comprising:

one or more frozen solvent particles of at least one of acetone, ethyl acetate, dimethyl formamide, dioxane, tetrahydrofuran, acetronitrile, hexamethylphosphorotriamide, tert-butyl alcohol, formic acid, hydrogen fluoride, ammonia, benzene, carbon tetrachloride, acetonitrile, hexane, dichloromethane, methylene chloride, methane, toluene, chloroform, or diethyl ether, and

including at least one biological remodeling agent of one or more pegylated cytokine.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: THE INVENTION SCIENCE FUND I LLC
To: GEARBOX, LLC
Reel/Frame 037540/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2013
From: SEARETE LLC
To: THE INVENTION SCIENCE FUND I, LLC
Reel/Frame 031079/0954 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2009
From: BOYDEN, EDWARD S.; COOK, DANIEL B.; HYDE, RODERICK A.; LEUTHARDT, ERIC C.; MYHRVOLD, NATHAN P.; SWEENEY, ELIZABETH A.; WOOD, JR., LOWELL L.
To: SEARETE LLC
Reel/Frame 022864/0034 →